{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:57:52Z","timestamp":1758121072725,"version":"3.44.0"},"reference-count":39,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,8,3]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>Congenital thrombotic thrombocytopaenic purpura (cTTP) is an extremely rare disease, and kidney transplantation in this population is even rarer. Finding an appropriate immunosuppressive regimen in cTTP transplant recipients can be challenging, as calcineurin inhibitors are associated with an increased risk of thrombotic microangiopathy (TMA), whereas prophylactic plasma exchange reduces the blood concentrations of mycophenolic acid and belatacept. We discuss a kidney allograft recipient with cTTP having repeated episodes of T-cell-mediated rejection with systemic TMA. Changes to his immunosuppressive regimen and intensification of plasma exchange therapy terminated TMA temporarily but failed to prevent its recurrence. Ultimately, he was treated with recombinant a disintegrin and metalloproteinase with a thrombospondin type one motif, member 13 (ADAMTS13) infusions, halting TMA and preventing future episodes. This is the first case of prophylaxis with recombinant ADAMTS13 in a kidney allograft recipient, illustrating its potential benefit over plasma exchange by assuring therapeutic immunosuppressants\u2019 concentrations and preventing both rejection and TMA-induced graft injury.<\/jats:p>","DOI":"10.1136\/bcr-2025-267099","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T07:35:32Z","timestamp":1755416132000},"page":"e267099","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Kidney transplantation in congenital thrombotic thrombocytopaenic purpura: using recombinant ADAMTS13 to balance relapse and rejection"],"prefix":"10.1136","volume":"18","author":[{"given":"Simon Cornelis","family":"Zethof","sequence":"first","affiliation":[{"name":"Department of internal medicine, Medisch Centrum Haaglanden Westeinde, The Hague, ZH, The Netherlands"},{"name":"Department of internal medicine, Leiden University Medical Center, Leiden, ZH, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Netelenbos","sequence":"additional","affiliation":[{"name":"Haematology, HagaZiekenhuis Locatie Leyweg, Den Haag, Zuid-Holland, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of internal medicine, Leiden University Medical Center, Leiden, ZH, The Netherlands"},{"name":"Leiden Transplant Center, Leiden University Medical Center, Leiden, ZH, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris","family":"Rotmans","sequence":"additional","affiliation":[{"name":"Department of internal medicine, Leiden University Medical Center, Leiden, ZH, The Netherlands"},{"name":"Leiden Transplant Center, Leiden University Medical Center, Leiden, ZH, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"2025081700352736000_18.8.e267099.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1312353"},{"key":"2025081700352736000_18.8.e267099.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-709857"},{"key":"2025081700352736000_18.8.e267099.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-884700"},{"key":"2025081700352736000_18.8.e267099.4","first-page":"00360","article-title":"2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura","volume":"17","author":"Zheng","year":"2025","journal-title":"J Thromb Haemost"},{"key":"2025081700352736000_18.8.e267099.5","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/oxfordjournals.ndt.a027673","article-title":"Renal transplantation in adults with thrombotic thrombocytopenic purpura\/haemolytic-uraemic syndrome","volume":"11","author":"Conlon","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"2025081700352736000_18.8.e267099.6","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/jth.14815","article-title":"A multi-center evaluation of TECHNOSCREEN\u00ae ADAMTS-13 activity assay as a screening tool for detecting deficiency of ADAMTS-13","volume":"18","author":"Moore","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2025081700352736000_18.8.e267099.7","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22043"},{"key":"2025081700352736000_18.8.e267099.8","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/bcp.13755","article-title":"Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device","volume":"84","author":"Zwart","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"2025081700352736000_18.8.e267099.9","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.3389\/ti.2024.12283","article-title":"European Survey on Clinical Practice of Detecting and Treating T-Cell Mediated Kidney Transplant Rejection","volume":"37","author":"Koshy","year":"2024","journal-title":"Transpl Int"},{"key":"2025081700352736000_18.8.e267099.10","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJMoa2314793","article-title":"Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura","volume":"390","author":"Scully","year":"2024","journal-title":"N Engl J Med"},{"key":"2025081700352736000_18.8.e267099.11","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.121"},{"key":"2025081700352736000_18.8.e267099.12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ekir.2017.06.007","article-title":"Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura","volume":"2","author":"Little","year":"2017","journal-title":"Kidney Int Rep"},{"key":"2025081700352736000_18.8.e267099.13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.216796"},{"key":"2025081700352736000_18.8.e267099.14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04760512"},{"key":"2025081700352736000_18.8.e267099.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07116.x"},{"key":"2025081700352736000_18.8.e267099.16","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.3892\/mmr.2014.3041","article-title":"Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty","volume":"11","author":"Liu","year":"2015","journal-title":"Mol Med Rep"},{"key":"2025081700352736000_18.8.e267099.17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9516"},{"key":"2025081700352736000_18.8.e267099.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-2977(01)00127-9"},{"key":"2025081700352736000_18.8.e267099.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03178.x"},{"key":"2025081700352736000_18.8.e267099.20","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.3389\/ti.2023.11590","article-title":"Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria","volume":"36","author":"Afrouzian","year":"2023","journal-title":"Transpl Int"},{"key":"2025081700352736000_18.8.e267099.21","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001239","article-title":"Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss","volume":"7","author":"Petr","year":"2021","journal-title":"Transplant Direct"},{"key":"2025081700352736000_18.8.e267099.22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.702506"},{"key":"2025081700352736000_18.8.e267099.23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/jcm12030758","article-title":"Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura?","volume":"12","author":"Cauchois","year":"2023","journal-title":"J Clin Med"},{"key":"2025081700352736000_18.8.e267099.24","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/jcm8122084","article-title":"Plasmapheresis Reduces Mycophenolic Acid Concentration: A Study of Full AUC0-12 in Kidney Transplant Recipients","volume":"8","author":"Piyasiridej","year":"2019","journal-title":"J Clin Med"},{"key":"2025081700352736000_18.8.e267099.25","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1097\/TP.0000000000003840","article-title":"Plasmapheresis Decreases Belatacept Exposure: Requires Consideration for Dose and Frequency Adjustments","volume":"105","author":"Jain","year":"2021","journal-title":"Transplantation"},{"key":"2025081700352736000_18.8.e267099.26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/ajkd.2001.24536","article-title":"Impact of therapeutic plasma exchange on cyclosporine kinetics during membrane-based lipid apheresis","volume":"37","author":"Balogun","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2025081700352736000_18.8.e267099.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021587","article-title":"Phenotypic expression of ADAMTS13 in glomerular endothelial cells","volume":"6","author":"Tati","year":"2011","journal-title":"PLoS ONE"},{"key":"2025081700352736000_18.8.e267099.28","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017060679"},{"key":"2025081700352736000_18.8.e267099.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03692.x"},{"key":"2025081700352736000_18.8.e267099.30","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1111\/jcmm.15025","article-title":"Novel mutations in ADAMTS13 CUB domains cause abnormal pre-mRNA splicing and defective secretion of ADAMTS13","volume":"24","author":"Jiang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"2025081700352736000_18.8.e267099.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601561"},{"key":"2025081700352736000_18.8.e267099.32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-378638"},{"key":"2025081700352736000_18.8.e267099.33","doi-asserted-by":"publisher","DOI":"10.1126\/science.1170905"},{"key":"2025081700352736000_18.8.e267099.34","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/trf.14326","article-title":"Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome)","volume":"57","author":"Fattah","year":"2017","journal-title":"Transfusion"},{"key":"2025081700352736000_18.8.e267099.35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-156"},{"key":"2025081700352736000_18.8.e267099.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7933.2004.00623.x"},{"key":"2025081700352736000_18.8.e267099.37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08860220902839121","article-title":"Transient hemolytic anemia after kidney transplantation and thrombotic thrombocytopenic purpura refractory to plasma exchange and rituximab","volume":"31","author":"Pieringer","year":"2009","journal-title":"Ren Fail"},{"key":"2025081700352736000_18.8.e267099.38","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200210270-00003"},{"key":"2025081700352736000_18.8.e267099.39","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.219063"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-267099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T07:35:34Z","timestamp":1755416134000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-267099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,16]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bcr-2025-267099"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-267099","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}